Medanta Q1 results: PAT rises by 4% to Rs 106 cr, revenue at Rs 861 cr

Q: How long will it take to read this news story?

The story "Medanta Q1 results: PAT rises by 4% to Rs 106 cr, revenue at Rs 861 cr" has 319 words across 13 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Medanta Q1 results: PAT rises by 4% to Rs 106 cr, revenue at Rs 861 cr" was covered 8 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 283 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21998533</li><li>URL: https://beamstart.com/news/medanta-q1-results-pat-rises-17232027664512</li></ul>

Business Standard Logo Business Standard 8h ago

Medanta Q1 results: PAT rises by 4% to Rs 106 cr, revenue at Rs 861 cr - Business Standard

Quick Summary:

Global Health, which operates hospitals under the Medanta brand, on Friday said its consolidated profit after tax increased 4 per cent year on year to Rs 106 crore for the first quarter ended June 30, 2024.

Medanta Chairman & Managing Director Naresh Trehan said that on July 22, 2024, the company has received confirmation from the Mumbai Housing and Area Development Authority (MHADA) regarding a successful bid for a land parcel measuring 8,859.24 square meter at Mauje-Oshiwara, Jogeshwari, Mumbai.

Revenue from operations rose to Rs 861 crore in the June quarter as compared to Rs 779 crore in the year-ago period, Global Health said in a regulatory filing.